Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Qingsong Zhu


Insilico Medicine has hired Qingsong Zhu to serve as its chief operating officer. In this role, he will be in charge of the company's operations and drug discovery research initiatives.

Prior to joining the company, Zhu spent seven years as a postdoctoral research fellow in the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University and has also worked as an independent consultant to apply next-generation sequencing to develop diagnostics and personalized medicine. Zhu holds a bachelors degree in biology from the Beijing Forestry University in Beijing and doctorate in biochemistry from Kansas State University.

Filed under

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.